BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7879797)

  • 1. Acute liver failure linked to felbamate use.
    Am J Hosp Pharm; 1994 Dec; 51(23):2882, 2887. PubMed ID: 7879797
    [No Abstract]   [Full Text] [Related]  

  • 2. Felbamate-associated fatal acute hepatic necrosis.
    O'Neil MG; Perdun CS; Wilson MB; McGown ST; Patel S
    Neurology; 1996 May; 46(5):1457-9. PubMed ID: 8628501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary mania associated with the use of felbamate.
    Hill RR; Stagno SJ; Tesar GE
    Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143
    [No Abstract]   [Full Text] [Related]  

  • 4. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Oct; 272(13):995. PubMed ID: 8089899
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic drug monitoring of felbamate].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate: restrictions on use.
    Farrington E
    Pediatr Nurs; 1995; 21(2):188, 200. PubMed ID: 7746687
    [No Abstract]   [Full Text] [Related]  

  • 7. New antiepilepsy drug, felbamate, marketed.
    Clin Pharm; 1993 Oct; 12(10):713. PubMed ID: 8258253
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytopenia in association with adjunctive felbamate use.
    Ney GC; Schaul N; Loughlin J; Rai K; Chandra V
    Neurology; 1994 May; 44(5):980-1. PubMed ID: 8190314
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA recommends taking patients off Felbatol.
    RDH; 1994 Sep; 14(9):36. PubMed ID: 8619071
    [No Abstract]   [Full Text] [Related]  

  • 10. Felbamate: 1997 update.
    Pellock JM; Brodie MJ
    Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosis associated with felbamate treatment.
    Knable MB; Rickler K
    J Clin Psychopharmacol; 1995 Aug; 15(4):292-3. PubMed ID: 7593718
    [No Abstract]   [Full Text] [Related]  

  • 12. Involuntary movement disorders associated with felbamate.
    Kerrick JM; Kelley BJ; Maister BH; Graves NM; Leppik IE
    Neurology; 1995 Jan; 45(1):185-7. PubMed ID: 7824115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric effects of felbamate.
    Ketter TA; Malow BA; Post RM; Theodore WH
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):118-9. PubMed ID: 9017538
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment: warfarin-felbamate interaction.
    Glue P; Banfield CR; Colucci RD; Perhach JL
    Ann Pharmacother; 1994 Dec; 28(12):1412-3. PubMed ID: 7696739
    [No Abstract]   [Full Text] [Related]  

  • 15. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
    Pennell PB; Ogaily MS; Macdonald RL
    Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate: a new antiepileptic drug.
    Brodie MJ
    Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
    [No Abstract]   [Full Text] [Related]  

  • 17. Taming the brain storms: felbamate updated.
    Brodie MJ; Pellock JM
    Lancet; 1995 Oct; 346(8980):918-9. PubMed ID: 7564721
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin-felbamate interaction: first report.
    Tisdel KA; Israel DS; Kolb KW
    Ann Pharmacother; 1994 Jun; 28(6):805. PubMed ID: 7919574
    [No Abstract]   [Full Text] [Related]  

  • 19. Rectal administration of felbamate in a child with Lennox-Gastaut syndrome.
    Grossmann R; Maytal J; Fernando J
    Neurology; 1994 Oct; 44(10):1979. PubMed ID: 7936261
    [No Abstract]   [Full Text] [Related]  

  • 20. 27-year-old woman with pancytopenia.
    Rayson D; Kang EM; Inwards DJ
    Mayo Clin Proc; 1995 Feb; 70(2):185-8. PubMed ID: 7845045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.